Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedLocation entry changed from Napoli, Italy, 80131 to Naples, Italy, 80131, and the page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded revision note v3.4.3 and removed v3.4.2 from the page.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing the former v3.4.1. This update does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. This is a minor version update and does not affect study content, eligibility criteria, outcomes, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedUI and text updates include adding a glossary toggle (Show/Hide glossary), adjusting the QC criterion label from previous wording to a new one, and adding 'No FEAR Act Data' and 'Revision: v3.4.0' notes. These changes do not affect the study content or critical study information.SummaryDifference0.1%

- Check81 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.